Related Experiment Video

Updated: Mar 3, 2026

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

1.0K

Developmental origins of brain tumors

Chong Liu1, Hui Zong

  • 1Institute of Molecular Biology, University of Oregon, Eugene, OR 97403, United States.

Current Opinion in Neurobiology
|May 8, 2012
PubMed

Insights

Brain tumor development involves intricate interactions between gene mutations and cellular development. Understanding these origins, including cell types and genetic mutations, is key to developing effective brain tumor therapies.

Area of Science:

  • Neuro-oncology
  • Developmental Biology
  • Genetics

Background:

  • Brain tumors, including ependymoma, medulloblastoma, and malignant glioma, have high fatality rates and significantly impact patient quality of life.
  • Recent advancements in comparative transcriptome profiling and mouse genetic models have enhanced understanding of brain tumor origins.
  • This knowledge is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To review recent progress in understanding the developmental origins of ependymoma, medulloblastoma, and malignant glioma.
  • To synthesize findings into a conceptual framework explaining brain tumor formation.
  • To highlight the interplay between genetic mutations and developmental programs in tumorigenesis.

Main Methods:

  • Review of recent scientific literature on brain tumor development.
  • Analysis of comparative transcriptome profiling data.
  • Examination of findings from mouse genetic models.

Main Results:

  • Brain tumor subtypes originate from distinct cell types.
  • Specific genetic mutations uniquely affect certain cell-of-origin types.
  • Mutant stem cells may require differentiation into progenitor cells to initiate transformation.

Conclusions:

  • Brain tumor formation is a complex process involving gene mutations and developmental programs.
  • Distinct cell-of-origin and mutation susceptibility contribute to tumor heterogeneity.
  • Targeting developmental pathways alongside genetic mutations may offer novel therapeutic avenues.

More Related Videos

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.7K
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.7K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
815
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K